CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594 | -80.9% | 21,605 | -69.0% | 0.01% | -86.4% |
| Q4 2022 | $3,110 | -99.6% | 69,796 | +240.7% | 0.04% | +780.0% |
| Q4 2021 | $791,000 | -65.2% | 20,487 | -81.4% | 0.01% | -78.3% |
| Q1 2021 | $2,272,000 | +28.5% | 110,306 | +9.3% | 0.02% | -36.1% |
| Q4 2020 | $1,768,000 | – | 100,919 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|